SCHEMBL3114099

SCHEMBL3114099

C=CCCCCC(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9299029 0.97 MAPT (0.67)
SCHEMBL16758454 0.97 MAPT (0.67)
SCHEMBL5066976 0.97 MAPT (0.67)
SCHEMBL24287565 0.97 MAPT (0.67)
SCHEMBL9856658 0.97 MAPT (0.67)
SCHEMBL25269893 0.97 MAPT (0.67)
SCHEMBL3119162 0.97 MAPT (0.67)
SCHEMBL10548401 0.97 MAPT (0.67)
SCHEMBL3127526 0.97 MAPT (0.67)
SCHEMBL3982551 0.97 MAPT (0.67)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636279-A1 POLY AND COPOLY (N -VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS Applera Corporation (US) 2006-03-22 EP claimed
WO-2004104054-A1 POLY AND COPOLY (N-VINYLAMIDE)S AND THEIR USE IN CAPILLARY ELECTROPHORESIS APPLERA CORPORATION (US) 2004-12-02 WO claimed
US-20260062435-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD (SG) 2026-03-05 US disclosed
US-20240175018-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD. (SG) 2024-05-30 US disclosed
CN-111417620-B Creatine prodrugs, compositions thereof, and methods of use 奥特吉尼克斯制药公司 2023-08-25 CN disclosed
US-20220168385-A1 USE OF CYCLOSPORINE ANALOGUES AS ANTITHROMBOTIC AGENTS ACHILLE LIFE SCIENCES LIMITED (GB) 2022-06-02 US disclosed
WO-2022115651-A1 USE OF CYCLOSPORINE ANALOGUES AS ANTITHROMBOTIC AGENTS HEPION PHARMACEUTICALS, INC. (US) 2022-06-02 WO disclosed
CN-110627717-B Branched 1, 4-diene amide derivative and synthesis method thereof 杭州师范大学 2021-01-26 CN disclosed
WO-2021005131-A1 COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF 3B PHARMACEUTICALS GMBH (DE) 2021-01-14 WO disclosed
CN-111417620-A Creatine prodrugs, compositions thereof, and methods of use 奥特吉尼克斯制药公司 2020-07-14 CN disclosed
WO-2020066510-A1 METHOD FOR PRODUCING POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT 住友化学株式会社 2020-04-02 WO disclosed
US-20040122192-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. 2004-06-24 US disclosed
EP-1368352-A1 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS Pfizer Limited (GB) 2003-12-10 EP disclosed
US-20020156207-A1 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition containing the copolymer, and uses thereof MITSUI CHEMICALS, INC. (JP) 2002-10-24 US disclosed
WO-2002074774-A1 CYCLIC GUANOSINE 3',5'-MONOPHOSPHATE PHOSPHODIESTERASE INHIBITORS PFIZER LIMITED (GB) 2002-09-26 WO disclosed
EP-1186619-A2 Polar group-containing olefin copolymer, process for preparing the same, thermoplastic resin composition contaning the copolymer, and uses thereof Mitsui Chemicals, Inc. (JP) 2002-03-13 EP disclosed
EP-0799713-B1 Thermal transfer donor element comprising a colourless sublimable compound and image forming process MINNESOTA MINING & MFG (US) 2000-07-19 EP disclosed
WO-2000040663-A1 ADHESION PROMOTERS LOCTITE (R & D) LIMITED (IE) 2000-07-13 WO disclosed
US-5747217-A GRAPHIC ARTS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-05-05 US disclosed
EP-0799713-A1 Thermal transfer donor element comprising a colourless sublimable compound and image forming process MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-10-08 EP disclosed